C07C 335/00
Thioureas, i.e. compounds containing any of the groups [image cpc-sch-c07c-0983.gif], the nitrogen
Official title: Thioureas, i.e. compounds containing any of the groups [IMAGE cpc-sch-C07C-0983.gif], the nitrogen atoms not being part of nitro or nitroso groups
C07C335/00 (Thioureas, i.e. compounds containing any of the groups [image cpc-sch-c07c-0983.gif], the nitrogen) appears on 854 US grants and 567 published applications in this corpus.
Search patents in C07C- Granted patents
- 854
- Published applications
- 567
- Assignees
- 448
- Inventors
- 2,294
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 31 | 0 |
| 1977 | 34 | 0 |
| 1978 | 23 | 0 |
| 1979 | 12 | 0 |
| 1980 | 20 | 0 |
| 1981 | 12 | 0 |
| 1982 | 22 | 0 |
| 1983 | 8 | 0 |
| 1984 | 17 | 0 |
| 1985 | 15 | 0 |
| 1986 | 11 | 0 |
| 1987 | 14 | 0 |
| 1988 | 16 | 0 |
| 1989 | 13 | 0 |
| 1990 | 13 | 0 |
| 1991 | 17 | 0 |
| 1992 | 18 | 0 |
| 1993 | 18 | 0 |
| 1994 | 12 | 0 |
| 1995 | 25 | 0 |
| 1996 | 15 | 0 |
| 1997 | 30 | 0 |
| 1998 | 16 | 0 |
| 1999 | 12 | 0 |
| 2000 | 24 | 0 |
| 2001 | 24 | 4 |
| 2002 | 25 | 31 |
| 2003 | 23 | 27 |
| 2004 | 15 | 42 |
| 2005 | 18 | 28 |
| 2006 | 15 | 18 |
| 2007 | 14 | 15 |
| 2008 | 15 | 22 |
| 2009 | 11 | 29 |
| 2010 | 13 | 26 |
| 2011 | 14 | 20 |
| 2012 | 15 | 16 |
| 2013 | 9 | 28 |
| 2014 | 21 | 30 |
| 2015 | 28 | 19 |
| 2016 | 21 | 40 |
| 2017 | 30 | 37 |
| 2018 | 17 | 17 |
| 2019 | 19 | 18 |
| 2020 | 12 | 16 |
| 2021 | 9 | 13 |
| 2022 | 8 | 14 |
| 2023 | 8 | 13 |
| 2024 | 8 | 9 |
| 2025 | 10 | 17 |
| 2026 | 4 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Dihydrooxazole and thiourea derivatives modulating the NLRP3 inflammasome pathway12 May 2026US 12,624,010 B2AC Immune SA
- Cationic lipid compound, and preparation method therefor and use thereof10 Mar 2026US 12,569,449 B1Rongcan (Shanghai) Biotech Co., Ltd.
- Composition for tin-silver alloy electroplating comprising a complexing agent24 Feb 2026US 12,559,852 B2BASF SE
- Acyclic lipids and methods of use thereof10 Feb 2026US 12,545,636 B2ReNAgade Therapeutics Management Inc.
- Inhibitor of EIF2α dephosphorylation16 Dec 2025US 12,497,358 B2The Royal Institution for the Advancement of Learning/Mcgill University
- Lipid nanoparticle for targeted delivery of therapeutic payloads24 Sep 2026US 2026/0285801 A1Trustees of Tufts College
- Degradable cationic lipid containing a disulfide bond and applications thereof13 Aug 2026US 2026/0234104 A1Xiamen Sinopeg Biotech Co., Ltd.
- A strategy for the selective removal of mri contrast agents6 Aug 2026US 2026/0226079 A1Portland State University
- Compounds and compositions for treating conditions associated with nlrp activity16 Jul 2026US 2026/0200880 A1Novartis AG
- Masp-2 inhibitors and methods of use9 Jul 2026US 2026/0193179 A9Omeros Corporation
Most cited
By later US patents
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding125US 5,326,856 ACytogen Corporation · 1994
- Thiol-modified hyaluronan121US 6,884,788 B2Anika Therapeutics, Inc. · 2005
- Ligands for metabotropic glutamate receptors and inhibitors of NAALADase119US 6,528,499 B1Georgetown University · 2003
- Chemical compounds as inhibitors of amyloid beta protein production110US 5,624,937 AEli Lilly and Company · 1997